Metabolic transformation of cancer cells leads to the accumulation of lactate and significant acidification in the tumor microenvironment. Both lactate and acidosis have a well-documented impact on cancer progression and negative patient prognosis. Here, we report that cancer cells adapted to acidosis are significantly more sensitive to oxidative damage induced by hydrogen peroxide, high-dose ascorbate, and photodynamic therapy. Higher lactate concentrations abrogate the sensitization. Mechanistically, acidosis leads to a drop in antioxidant capacity caused by a compromised supply of nicotinamide adenine dinucleotide phosphate (NADPH) derived from glucose metabolism. However, lactate metabolism in the Krebs cycle restores NADPH supply and antioxidant capacity. CPI-613 (devimistat), an anticancer drug candidate, selectively eradicates the cells adapted to acidosis through inhibition of the Krebs cycle and induction of oxidative stress while completely abrogating the protective effect of lactate. Simultaneous cell treatment with tetracycline, an inhibitor of the mitochondrial proteosynthesis, further enhances the cytotoxic effect of CPI-613 under acidosis and in tumor spheroids. While there have been numerous attempts to treat cancer by neutralizing the pH of the tumor microenvironment, we alternatively suggest considering tumor acidosis as the Achilles' heel of cancer as it enables selective therapeutic induction of lethal oxidative stress.

4th Department of Internal Medicine Faculty General Hospital and 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic

Department of Biochemistry and Microbiology University of Chemistry and Technology Prague 166 28 Prague Czech Republic

Department of Biotechnology University of Chemistry and Technology Prague 166 28 Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Diagnostics Faculty General Hospital and 1st Faculty of Medicine Charles University 120 00 Prague Czech Republic

Institute of Microbiology The Czech Academy of Sciences 140 00 Prague Czech Republic

Zobrazit více v PubMed

Liberti M.V., Locasale J.W. The warburg effect: How does it benefit cancer cells? Trends Biochem. Sci. 2016;41:211–218. doi: 10.1016/j.tibs.2015.12.001. PubMed DOI PMC

Becker H.M. Carbonic anhydrase ix and acid transport in cancer. Br. J. Cancer. 2020;122:157–167. doi: 10.1038/s41416-019-0642-z. PubMed DOI PMC

Martinez-Outschoorn U.E., Peiris-Pagés M., Pestell R.G., Sotgia F., Lisanti M.P. Cancer metabolism: A therapeutic perspective. Nat. Rev. Clin. Oncol. 2017;14:11–31. doi: 10.1038/nrclinonc.2016.60. PubMed DOI

Roland C.L., Arumugam T., Deng D., Liu S.H., Philip B., Gomez S., Burns W.R., Ramachandran V., Wang H., Cruz-Monserrate Z., et al. Cell surface lactate receptor gpr81 is crucial for cancer cell survival. Cancer Res. 2014;74:5301–5310. doi: 10.1158/0008-5472.CAN-14-0319. PubMed DOI PMC

LeBleu V.S., O’Connell J.T., Gonzalez Herrera K.N., Wikman H., Pantel K., Haigis M.C., de Carvalho F.M., Damascena A., Domingos Chinen L.T., Rocha R.M., et al. Pgc-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 2014;16:992–1003. doi: 10.1038/ncb3039. PubMed DOI PMC

Blatt S., Voelxen N., Sagheb K., Pabst A.M., Walenta S., Schroeder T., Mueller-Klieser W., Ziebart T. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (hnscc) post radiation: A prospective study over 15 years. Clin. Oral Investig. 2016;20:2097–2104. doi: 10.1007/s00784-015-1699-6. PubMed DOI

Walenta S., Wetterling M., Lehrke M., Schwickert G., Sundfør K., Rofstad E.K., Mueller-Klieser W. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916–921. PubMed

Thews O., Riemann A. Tumor ph and metastasis: A malignant process beyond hypoxia. Cancer Metastasis Rev. 2019;38:113–129. doi: 10.1007/s10555-018-09777-y. PubMed DOI

Robey I.F., Baggett B.K., Kirkpatrick N.D., Roe D.J., Dosescu J., Sloane B.F., Hashim A.I., Morse D.L., Raghunand N., Gatenby R.A., et al. Bicarbonate increases tumor ph and inhibits spontaneous metastases. J. Cancer Res. 2009;69:2260–2268. doi: 10.1158/0008-5472.CAN-07-5575. PubMed DOI PMC

Gottfried E., Kunz-Schughart L.A., Ebner S., Mueller-Klieser W., Hoves S., Andreesen R., Mackensen A., Kreutz M. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006;107:2013–2021. doi: 10.1182/blood-2005-05-1795. PubMed DOI

Colegio O.R., Chu N.Q., Szabo A.L., Chu T., Rhebergen A.M., Jairam V., Cyrus N., Brokowski C.E., Eisenbarth S.C., Phillips G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559–563. doi: 10.1038/nature13490. PubMed DOI PMC

Lee D.C., Sohn H.A., Park Z.Y., Oh S., Kang Y.K., Lee K.M., Kang M., Jang Y.J., Yang S.J., Hong Y.K., et al. A lactate-induced response to hypoxia. Cell. 2015;161:595–609. doi: 10.1016/j.cell.2015.03.011. PubMed DOI

McDonald P.C., Chia S., Bedard P.L., Chu Q., Lyle M., Tang L., Singh M., Zhang Z., Supuran C.T., Renouf D.J., et al. A phase 1 study of slc-0111, a novel inhibitor of carbonic anhydrase ix, in patients with advanced solid tumors. Am. J. Clin. Oncol. 2020;43:484–490. doi: 10.1097/COC.0000000000000691. PubMed DOI PMC

Lou Y., McDonald P.C., Oloumi A., Chia S., Ostlund C., Ahmadi A., Kyle A., Auf dem Keller U., Leung S., Huntsman D., et al. Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase ix inhibitors. Cancer Res. 2011;71:3364–3376. doi: 10.1158/0008-5472.CAN-10-4261. PubMed DOI

Le A., Cooper C.R., Gouw A.M., Dinavahi R., Maitra A., Deck L.M., Royer R.E., Vander Jagt D.L., Semenza G.L., Dang C.V. Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. USA. 2010;107:2037–2042. doi: 10.1073/pnas.0914433107. PubMed DOI PMC

Xie H., Hanai J., Ren J.G., Kats L., Burgess K., Bhargava P., Signoretti S., Billiard J., Duffy K.J., Grant A., et al. Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab. 2014;19:795–809. doi: 10.1016/j.cmet.2014.03.003. PubMed DOI PMC

Doherty J.R., Cleveland J.L. Targeting lactate metabolism for cancer therapeutics. J. Clin. Investig. 2013;123:3685–3692. doi: 10.1172/JCI69741. PubMed DOI PMC

Bola B.M., Chadwick A.L., Michopoulos F., Blount K.G., Telfer B.A., Williams K.J., Smith P.D., Critchlow S.E., Stratford I.J. Inhibition of monocarboxylate transporter-1 (mct1) by azd3965 enhances radiosensitivity by reducing lactate transport. Mol. Cancer Ther. 2014;13:2805–2816. doi: 10.1158/1535-7163.MCT-13-1091. PubMed DOI PMC

Kuo T.C., Huang K.Y., Yang S.C., Wu S., Chung W.C., Chang Y.L., Hong T.M., Wang S.P., Chen H.Y., Hsiao T.H., et al. Monocarboxylate transporter 4 is a therapeutic target in non-small cell lung cancer with aerobic glycolysis preference. Mol. Ther. Oncolytics. 2020;18:189–201. doi: 10.1016/j.omto.2020.06.012. PubMed DOI PMC

Gorrini C., Harris I.S., Mak T.W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 2013;12:931–947. doi: 10.1038/nrd4002. PubMed DOI

Zelenka J., Koncošová M., Ruml T. Targeting of stress response pathways in the prevention and treatment of cancer. Biotechnol. Adv. 2018;36:583–602. doi: 10.1016/j.biotechadv.2018.01.007. PubMed DOI

Piskounova E., Agathocleous M., Murphy M.M., Hu Z., Huddlestun S.E., Zhao Z., Leitch A.M., Johnson T.M., DeBerardinis R.J., Morrison S.J. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186–191. doi: 10.1038/nature15726. PubMed DOI PMC

Sayin V.I., Ibrahim M.X., Larsson E., Nilsson J.A., Lindahl P., Bergo M.O. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 2014;6:221ra215. doi: 10.1126/scitranslmed.3007653. PubMed DOI

Lopes-Coelho F., Gouveia-Fernandes S., Gonçalves L.G., Nunes C., Faustino I., Silva F., Félix A., Pereira S.A., Serpa J. Hnf1β drives glutathione (gsh) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (occc) Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 2016;37:4813–4829. doi: 10.1007/s13277-015-4290-5. PubMed DOI

Hammad A., Namani A., Elshaer M., Wang X.J., Tang X. “Nrf2 addiction” in lung cancer cells and its impact on cancer therapy. Cancer Lett. 2019;467:40–49. doi: 10.1016/j.canlet.2019.09.016. PubMed DOI

Zelenka J., Dvořák A., Alán L. L-lactate protects skin fibroblasts against aging-associated mitochondrial dysfunction via mitohormesis. Oxidative Med. Cell. Longev. 2015;2015:351698. doi: 10.1155/2015/351698. PubMed DOI PMC

Zhao M., Liu Q., Gong Y., Xu X., Zhang C., Liu X., Zhang C., Guo H., Zhang X., Gong Y., et al. Gsh-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment. Cell Cycle. 2016;15:1125–1133. doi: 10.1080/15384101.2016.1158374. PubMed DOI PMC

Lamonte G., Tang X., Chen J.L., Wu J., Ding C.K., Keenan M.M., Sangokoya C., Kung H.N., Ilkayeva O., Boros L.G., et al. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab. 2013;1:23. doi: 10.1186/2049-3002-1-23. PubMed DOI PMC

Gao J., Guo Z., Cheng J., Sun B., Yang J., Li H., Wu S., Dong F., Yan X. Differential metabolic responses in breast cancer cell lines to acidosis and lactic acidosis revealed by stable isotope assisted metabolomics. Sci. Rep. 2020;10:21967. doi: 10.1038/s41598-020-78955-2. PubMed DOI PMC

Hashimoto T., Hussien R., Oommen S., Gohil K., Brooks G.A. Lactate sensitive transcription factor network in l6 cells: Activation of mct1 and mitochondrial biogenesis. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2007;21:2602–2612. doi: 10.1096/fj.07-8174com. PubMed DOI

Tauffenberger A., Fiumelli H., Almustafa S., Magistretti P.J. Lactate and pyruvate promote oxidative stress resistance through hormetic ros signaling. Cell Death Dis. 2019;10:653. doi: 10.1038/s41419-019-1877-6. PubMed DOI PMC

Abrego J., Gunda V., Vernucci E., Shukla S.K., King R.J., Dasgupta A., Goode G., Murthy D., Yu F., Singh P.K. Got1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Lett. 2017;400:37–46. doi: 10.1016/j.canlet.2017.04.029. PubMed DOI PMC

Porporato P.E., Payen V.L., De Saedeleer C.J., Préat V., Thissen J.P., Feron O., Sonveaux P. Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice. Angiogenesis. 2012;15:581–592. doi: 10.1007/s10456-012-9282-0. PubMed DOI

Yang L., Hu X., Mo Y.Y. Acidosis promotes tumorigenesis by activating akt/nf-κb signaling. Cancer Metastasis Rev. 2019;38:179–188. doi: 10.1007/s10555-019-09785-6. PubMed DOI

Schoenfeld J.D., Alexander M.S., Waldron T.J., Sibenaller Z.A., Spitz D.R., Buettner G.R., Allen B.G., Cullen J.J. Pharmacological ascorbate as a means of sensitizing cancer cells to radio-chemotherapy while protecting normal tissue. Semin. Radiat. Oncol. 2019;29:25–32. doi: 10.1016/j.semradonc.2018.10.006. PubMed DOI PMC

Ying W. Nad+/nadh and nadp+/nadph in cellular functions and cell death: Regulation and biological consequences. Antioxid. Redox Signal. 2008;10:179–206. doi: 10.1089/ars.2007.1672. PubMed DOI

Chen X., Zhong Z., Xu Z., Chen L., Wang Y. 2′,7′-dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radic. Res. 2010;44:587–604. doi: 10.3109/10715761003709802. PubMed DOI

Corbet C., Bastien E., Santiago de Jesus J.P., Dierge E., Martherus R., Vander Linden C., Doix B., Degavre C., Guilbaud C., Petit L., et al. Tgfβ2-induced formation of lipid droplets supports acidosis-driven emt and the metastatic spreading of cancer cells. Nat. Commun. 2020;11:454. doi: 10.1038/s41467-019-14262-3. PubMed DOI PMC

Corbet C., Pinto A., Martherus R., Santiago de Jesus J.P., Polet F., Feron O. Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation. Cell Metab. 2016;24:311–323. doi: 10.1016/j.cmet.2016.07.003. PubMed DOI

Pérez-Escuredo J., Dadhich R.K., Dhup S., Cacace A., Van Hée V.F., De Saedeleer C.J., Sboarina M., Rodriguez F., Fontenille M.J., Brisson L., et al. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle. 2016;15:72–83. doi: 10.1080/15384101.2015.1120930. PubMed DOI PMC

Lamb R., Ozsvari B., Lisanti C.L., Tanowitz H.B., Howell A., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget. 2015;6:4569–4584. doi: 10.18632/oncotarget.3174. PubMed DOI PMC

Alistar A., Morris B.B., Desnoyer R., Klepin H.D., Hosseinzadeh K., Clark C., Cameron A., Leyendecker J., D’Agostino R., Jr., Topaloglu U., et al. Safety and tolerability of the first-in-class agent cpi-613 in combination with modified folfirinox in patients with metastatic pancreatic cancer: A single-centre, open-label, dose-escalation, phase 1 trial. Lancet. Oncol. 2017;18:770–778. doi: 10.1016/S1470-2045(17)30314-5. PubMed DOI PMC

Bellio C., DiGloria C., Spriggs D.R., Foster R., Growdon W.B., Rueda B.R. The metabolic inhibitor cpi-613 negates treatment enrichment of ovarian cancer stem cells. Cancers. 2019;11:1678. doi: 10.3390/cancers11111678. PubMed DOI PMC

Vasan K., Werner M., Chandel N.S. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32:341–352. doi: 10.1016/j.cmet.2020.06.019. PubMed DOI PMC

De Francesco E.M., Sotgia F., Lisanti M.P. Cancer stem cells (cscs): Metabolic strategies for their identification and eradication. Biochem. J. 2018;475:1611–1634. doi: 10.1042/BCJ20170164. PubMed DOI PMC

Hynek J., Koncošová M., Zelenka J., KříŽová I., Ruml T., Kubát P., Demel J., Lang K. Phosphinatophenylporphyrins tailored for high photodynamic efficacy. Org. Biomol. Chem. 2018;16:7274–7281. doi: 10.1039/C8OB01984C. PubMed DOI

Kirakci K., Zelenka J., Rumlová M., Cvačka J., Ruml T., Lang K. Cationic octahedral molybdenum cluster complexes functionalized with mitochondria-targeting ligands: Photodynamic anticancer and antibacterial activities. Biomater. Sci. 2019;7:1386–1392. doi: 10.1039/C8BM01564C. PubMed DOI

Darmostuk M., Jurášek M., Lengyel K., Zelenka J., Rumlová M., Drašar P., Ruml T. Conjugation of chlorins with spermine enhances phototoxicity to cancer cells in vitro. J. Photochem. Photobiol. BBiol. 2017;168:175–184. doi: 10.1016/j.jphotobiol.2017.02.012. PubMed DOI